Idera Pharmaceuticals, Inc. (IDRA) Reports Q4 Loss of $0.35/Share

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q4 EPS of ($0.35), versus ($0.21) reported last year.

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery